ReviewScience in One Health2025
One Health integrated surveillance: a way forward to accelerate schistosomiasis elimination in China.
Review in Science in One Health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Rapid and Sensitive Detection ofTropical medicine and infectious disease · 2026Article
- Development and field evaluation of a multiplex qPCR assay for environmental DNA detection of Schistosoma mekongi and its intermediate snail host Neotricula aperta in the Mekong River Basin.Infectious diseases of poverty · 2026Article
- Effectiveness of an Integrated One Health Intervention onChina CDC weekly · 2026Article
- Preventive Immunology for Livestock and Zoonotic Infectious Diseases in the One Health Era: From Mechanistic Insights to Innovative Interventions.Veterinary sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surveillance is an effective approach for disease control and prevention. Being a vector-borne and zoonotic parasitic disease, schistosomiasis has been under comprehensive surveillance in China for several decades, with focus on indicators related to definitive hosts, intermediate hosts, as well as changes of influencing factors. This article reviewed the surveillance system of schistosomiasis in China from the perspective of One Health to provide evidence for the acceleration of elimination. When moving towards elimination with rare new infection occurred in humans, livestock and snails, One Health surveillance system could be the most effective approach to accelerate the process of elimination or consolidate the achievement of schistosomiasis by integrating the risk surveillance and novel diagnostic tools in the intelligent multi-point trigger infectious disease monitoring and early warning system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.